drugset / Trial / NCT00360269

Atomoxetine Treatment for ADHD and Marijuana Dependence

NCT00360269

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence.

Timeline

Start
2005-11
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 25 mg
Subject Atomoxetine Other / unclassified 100 mg